Skip to main content

Our projects

Global Health EDCTP3 invests in global health through funding collaborative projects tackling infectious diseases and supporting activities for research capacity building in Africa.

Filter by

Our projects (109)

RSS
Showing results 40 to 60
Global Health EDCTP3-funded CRYPTOT&T project logo
  • In progress
  • Diarrhoeal diseases
Finding and treating Cryptosporidium parasite infectionsThe CryptoT&T project is developing a test to detect Cryptosporidium intestinal parasite infections, which could usher in targeted...
Global Health EDCTP3-funded EDCTP Africa Office project logo
  • In progress
  • Cross-disease or disease unspecific
This proposal is in response to the GH EDCTP3 call for support to EDCTP Africa Office (AO), which is part of the EDCTP Association Secretariat, based in Cape Town and hosted by the South...
Global Health EDCTP3-funded WINGS-4-FGS project logo
  • In progress
  • Neglected infectious diseases
Improving care of female genital schistosomiasisThe WINGS-4-FGS project is carrying out multiple activities to raise awareness, enhance detection and improve treatment of female genital...
Global Health EDCTP3-funded OPT-MVAC project logo
  • In progress
  • Malaria
Boosting malaria and other vaccine coverageThe OPT-MVAC project is exploring whether strengthening national malaria vaccine programmes can serve as a springboard for improved coverage of...
Global Health EDCTP3-funded EBO-PEP project logo
  • In progress
  • Emerging or re-emerging infectious diseases
Rapid protection against Ebola virusThe EBO-PEP project is evaluating whether monoclonal antibodies can protect close contacts of people with Ebola virus infections.
Global Health EDCTP3-funded EDCTP Association AO project logo
  • In progress
  • Cross-disease or disease unspecific
This proposal is submitted in response to the Global Health European and Developing Countries Clinical Trials Partnerhsip-3 (GH EDCTP3) Joint Undertaking (JU) call: “HORIZON-JU-EDCTP3-2025...
Global Health EDCTP3-funded IMPROVE-HPV project logo
  • In progress
  • Other childhood infectious diseases
Reducing cervical cancer by boosting HPV vaccination The IMPROVE-HPV project is exploring ways to improve take-up of vaccines against human papillomavirus (HPV), the main cause of cervical...
Global Health EDCTP3-funded JUA KIVU project logo
  • In progress
  • Emerging or re-emerging infectious diseases
We recently described the novel clade Ib mpox virus from Kamituga, South Kivu, which fast spread in the region and severe symptoms are the reason for the emergency call for mpox research...
Global Health EDCTP3-funded STROGHAT project logo
  • In progress
  • Neglected infectious diseases
Screen and treat for human African trypanosomiasisThe STROGHAT project will determine whether a new drug, acoziborole, can be used in a ‘screen-and-treat’ approach for control of human...
Global Health EDCTP3-funded MpoxVax AFRIVAC project logo
  • In progress
  • Emerging or re-emerging infectious diseases
The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and over 1,000 deaths, with women accounting for more...
Global Health EDCTP3-funded IVM-KIDS project logo
  • In progress
  • Neglected infectious diseases
Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...
Global Health EDCTP3-funded FAME project logo
  • In progress
  • Neglected infectious diseases
Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).
Global Health EDCTP3-funded PROTID project
  • In progress
  • Tuberculosis
TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...
Global Health EDCTP3-funded ASPIRE project logo
  • In progress
  • Lower respiratory tract infections
  • Other childhood infectious diseases
  • Cross-disease or disease unspecific
Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...
Global Health EDCTP3-funded IMPACTING project logo
  • In progress
  • Neglected infectious diseases
  • Malaria
  • Emerging or re-emerging infectious diseases
Targeting vectors for infection prediction and controlThe IMPACTING project is collecting data on a host of insect vectors that spread infections to help better predict the risk of...
Global Health EDCTP3-funded UTI-Diag project logo
  • In progress
  • Other childhood infectious diseases
  • Cross-disease or disease unspecific
Rapid testing of urinary tract infectionsThe UTI-Diag project is exploring whether point-of-care tests could improve detection and management of urinary tract infections (UTIs) and reduce...
Global Health EDCTP3-funded GREAT-LIFE project logo
  • In progress
  • Diarrhoeal diseases
  • Emerging or re-emerging infectious diseases
Enhancing genomic surveillance in the Great Lakes regionThe GREAT-LIFE project is building a genomics-based infrastructure to track existing and new infectious disease threats and...
Global Health EDCTP3-funded EpiTB project logo
  • In progress
  • Tuberculosis
Improving tuberculosis detection outside the lungsThe EpiTB project is assessing the clinical impact of a new diagnostic device that is better able to detect TB infections outside the lung.
Global Health EDCTP3-funded PDMC Saves Lives project logo
  • In progress
  • Malaria
Promoting use of malaria prevention after hospital discharge in childrenThe PDMC Saves Lives project is helping countries identify the best way to introduce a life-saving new approach to...
Global Health EDCTP3-funded LASR project logo
  • In progress
  • Malaria
  • Neglected infectious diseases
Disrupting mosquito feeding to prevent malariaThe LASR project is testing whether a newly developed mosquito repellent can reduce the community burden of malaria infections.